PASSAGE BIO INC's ticker is PASG and the CUSIP is 702712100. A total of 72 filers reported holding PASSAGE BIO INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $218,657 | -30.0% | 332,203 | +0.1% | 0.00% | – |
| Q2 2023 | $312,430 | -1.7% | 331,914 | 0.0% | 0.00% | – |
| Q1 2023 | $317,874 | +69304.8% | 331,914 | 0.0% | 0.00% | – |
| Q4 2022 | $458 | -99.9% | 331,914 | -5.8% | 0.00% | – |
| Q3 2022 | $440,000 | -47.0% | 352,537 | +0.2% | 0.00% | – |
| Q2 2022 | $830,000 | -58.5% | 351,727 | -45.5% | 0.00% | – |
| Q1 2022 | $2,000,000 | -53.2% | 645,311 | -4.0% | 0.00% | -100.0% |
| Q4 2021 | $4,269,000 | -9.4% | 672,325 | +42.0% | 0.00% | 0.0% |
| Q3 2021 | $4,714,000 | -32.7% | 473,328 | -10.5% | 0.00% | 0.0% |
| Q2 2021 | $7,005,000 | -9.8% | 529,095 | +19.0% | 0.00% | 0.0% |
| Q1 2021 | $7,769,000 | -5.4% | 444,490 | +38.4% | 0.00% | 0.0% |
| Q4 2020 | $8,211,000 | +193.0% | 321,119 | +50.2% | 0.00% | 0.0% |
| Q3 2020 | $2,802,000 | -51.5% | 213,747 | +1.1% | 0.00% | 0.0% |
| Q2 2020 | $5,779,000 | – | 211,461 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 2,497,922 | $63,872,000 | 14.76% |
| FRAZIER MANAGEMENT LLC | 5,009,219 | $128,086,000 | 9.86% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 602,248 | $15,399,000 | 7.53% |
| Vivo Capital, LLC | 1,487,038 | $38,024,000 | 1.70% |
| Boxer Capital, LLC | 1,928,315 | $49,307,000 | 1.58% |
| Orbimed Advisors | 6,962,899 | $178,041,000 | 1.56% |
| Logos Global Management LP | 344,438 | $8,807,000 | 0.76% |
| EMERALD ADVISERS, LLC | 340,698 | $8,712,000 | 0.29% |
| Ikarian Capital, LLC | 136,697 | $3,495,000 | 0.15% |
| Weiss Multi-Strategy Advisers LLC | 300,554 | $7,685,000 | 0.15% |